CHESTERFIELD, Mo., March 10 /PRNewswire-FirstCall/ -- Reliv International,
Inc. (Nasdaq: RELV), an international manufacturer and network marketer of
nutritional supplements and other food products, today announced that the
Board of Directors of Reliv has approved a program under which the company
intends to repurchase, under present market and business conditions, up to
$15 million at market price in shares of common stock of the company over the
ensuing 36 months. The number of shares to be repurchased and the timing of
the purchases will be at the discretion of the company's management and will
be influenced by factors including the market price of the common stock of the
company and results of operations. In announcing the anticipated purchases,
Robert L. Montgomery, Chairman, President and CEO, stated, "Current market
conditions have made repurchase by Reliv of its common stock an attractive use
of available funds at this time."
Reliv International, Inc., based in suburban St. Louis (USA), manufactures
and distributes several lines of food products, including nutritional and
fiber supplements, diet management products, functional foods, sports drink
mixes and premium skin care products. Reliv International's common stock
trades on The Nasdaq Stock Market(R) under the symbol RELV.
NOTE: Any statement released by Reliv International, Inc. that is forward
looking is made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements involve
risk and uncertainties that could cause actual results to differ materially
from the forward-looking statements. These includes economic, competitive,
governmental, technological and other factors discussed in the Company's
filings with the SEC on Forms 10-K and 10-Q.
SOURCE Reliv International, Inc.
 back to top
Company News On-Call:
http://www.prnewswire.com/comp/103123.html
CONTACT:
R. Scott Montgomery, Senior Vice
President-Worldwide Operations, +1-636-537-9715, Fred A. Nielson,
Investor Relations, +1-636-733-1314, both of Reliv International,
Inc.
|
